Skip to Main Content

Paper Details

Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort study.
BMC Pharmacol Toxicol
1
2022
COVID-19, COVID-19 disease, HRA, Patients, histamine, histamine-2 receptor, patients, respiratory disease
Author NameAffiliation
Seng Chan YouYonsei University College of Medicine
Seng Chan YouYonsei University College of Medicine
Jaehyeong ChoAjou University Graduate School of Medicine
Rae Woong ParkAjou University Graduate School of Medicine
Rae Woong ParkAjou University School of Medicine
Rae Woong ParkAjou University Graduate School of Medicine
Rae Woong ParkAjou University School of Medicine
  • 1 - 7

Datasets

Release 1.2